Inmune Bio, Inc. Files 8-K Report
Ticker: INMB · Form: 8-K · Filed: Sep 30, 2025 · CIK: 1711754
| Field | Detail |
|---|---|
| Company | Inmune Bio, Inc. (INMB) |
| Form Type | 8-K |
| Filed Date | Sep 30, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, 8-K
Related Tickers: INMB
TL;DR
INMB filed an 8-K on 9/29/25, updating corporate info. Nothing major disclosed yet.
AI Summary
On September 29, 2025, Inmune Bio, Inc. filed an 8-K report. The filing indicates the company's principal executive offices are located at 225 NE Mizner Blvd, Suite 640, Boca Raton, Florida. The report was filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Why It Matters
This filing serves as a public notification of significant corporate events or changes for Inmune Bio, Inc., providing transparency to investors and the market.
Risk Assessment
Risk Level: low — This filing is a routine corporate update and does not appear to contain material non-public information that would immediately impact the company's stock price.
Key Players & Entities
- Inmune Bio, Inc. (company) — Registrant
- September 29, 2025 (date) — Date of earliest event reported
- 225 NE Mizner Blvd, Suite 640, Boca Raton, Florida 33432 (address) — Principal Executive Offices
- 001-38793 (company_id) — Commission File Number
- 47-5205835 (company_id) — IRS Employer Identification No.
FAQ
What is the purpose of this Form 8-K filing for Inmune Bio, Inc.?
The Form 8-K is a Current Report filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, indicating a significant event or change for the company.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on September 29, 2025.
Where are Inmune Bio, Inc.'s principal executive offices located?
Inmune Bio, Inc.'s principal executive offices are located at 225 NE Mizner Blvd, Suite 640, Boca Raton, Florida 33432.
What is Inmune Bio, Inc.'s Commission File Number?
Inmune Bio, Inc.'s Commission File Number is 001-38793.
What is the IRS Employer Identification Number for Inmune Bio, Inc.?
The IRS Employer Identification Number for Inmune Bio, Inc. is 47-5205835.
Filing Stats: 476 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2025-09-30 16:05:40
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per shares INMB The NASDAQ Stock Ma
Filing Documents
- ea0258531-8k_inmune.htm (8-K) — 24KB
- ea025853101ex99-1_inmune.htm (EX-99.1) — 17KB
- ex99-1_001.jpg (GRAPHIC) — 2KB
- 0001213900-25-093930.txt ( ) — 210KB
- inmb-20250929.xsd (EX-101.SCH) — 3KB
- inmb-20250929_lab.xml (EX-101.LAB) — 33KB
- inmb-20250929_pre.xml (EX-101.PRE) — 22KB
- ea0258531-8k_inmune_htm.xml (XML) — 4KB
01. Other Events
Item 8.01. Other Events. On September 29, 2025, INmune Bio Inc. (the "Company") issued a press release announcing the submission of a manuscript, titled "XPro1595, a Selective Soluble TNF Neutralizer, in Early Alzheimer's Disease with Inflammation (ADi): Results from the Phase 2 MINDFuL Trial," detailing the results of the Company's Phase 2 MINDFuL trial for peer review to npj Dementia , a Nature Portfolio journal. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
01 Financial statements and Exhibits
Item 9.01 Financial statements and Exhibits (d) Exhibits. 99.1 Press Release, dated September 29, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INMUNE BIO INC. Date: September 30, 2025 By: /s/ David Moss David Moss Chief Executive Officer 2